Quick Answer
Alzamend Neuro, Inc. reported Shares Outstanding of 778.7 thousand shares for fiscal year 2025.
Alzamend Neuro, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 778,733 | +918.7% |
| 2024 | 76,444 | -88.2% |
| 2023 | 646,267 | -99.3% |
| 2022 | 95.48M | +41.6% |
| 2021 | 67.43M | +4.1% |
| 2020 | 64.76M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | 3.80M | -27.3% | +21.1% |
| July 31, 2025 | 3.14M | +264.5% | +303.2% |
| April 30, 2025 | 778,733 | +13.2% | -86.6% |
| January 31, 2025 | 5.80M | -12.4% | +10.8% |
| October 31, 2024 | 5.23M | -19.1% | +507.3% |
| July 31, 2024 | 861,332 | -99.1% | +25.2% |
| April 30, 2024 | 687,999 | -89.4% | -89.6% |
| January 31, 2024 | 6.62M | -93.1% | +2.3% |
- Alzamend Neuro, Inc. showed an increase of +918.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Alzamend Neuro, Inc.’s shares outstanding has declined by 98.8% (from 64.76 million shares to 778.7 thousand shares).
- The most recent figure is from Alzamend Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: